Published in J Mol Biol on February 26, 2009
Towards the understanding of resistance mechanisms in clinically isolated trimethoprim-resistant, methicillin-resistant Staphylococcus aureus dihydrofolate reductase. J Struct Biol (2009) 1.47
The challenge of developing robust drugs to overcome resistance. Drug Discov Today (2011) 1.43
Predicting resistance mutations using protein design algorithms. Proc Natl Acad Sci U S A (2010) 1.41
Toward new therapeutics for skin and soft tissue infections: propargyl-linked antifolates are potent inhibitors of MRSA and Streptococcus pyogenes. PLoS One (2012) 1.16
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1. Antimicrob Agents Chemother (2010) 1.07
Prospective screening of novel antibacterial inhibitors of dihydrofolate reductase for mutational resistance. Antimicrob Agents Chemother (2012) 0.99
Nonracemic Antifolates Stereoselectively Recruit Alternate Cofactors and Overcome Resistance in S. aureus. J Am Chem Soc (2015) 0.97
Antifolate agents: a patent review (2006 - 2010). Expert Opin Ther Pat (2011) 0.95
Acetylenic linkers in lead compounds: a study of the stability of the propargyl-linked antifolates. Drug Metab Dispos (2012) 0.91
Targeted mutations of Bacillus anthracis dihydrofolate reductase condense complex structure−activity relationships. J Med Chem (2010) 0.90
Protein design algorithms predict viable resistance to an experimental antifolate. Proc Natl Acad Sci U S A (2014) 0.90
Inhibition of bacterial dihydrofolate reductase by 6-alkyl-2,4-diaminopyrimidines. ChemMedChem (2012) 0.88
Crystal structures of Klebsiella pneumoniae dihydrofolate reductase bound to propargyl-linked antifolates reveal features for potency and selectivity. Antimicrob Agents Chemother (2014) 0.85
Elucidating features that drive the design of selective antifolates using crystal structures of human dihydrofolate reductase. Biochemistry (2013) 0.85
Kinetic and structural characterization of dihydrofolate reductase from Streptococcus pneumoniae. Biochemistry (2010) 0.83
Winning the arms race by improving drug discovery against mutating targets. ACS Chem Biol (2011) 0.81
Utility of the Biosynthetic Folate Pathway for Targets in Antimicrobial Discovery. Antibiotics (Basel) (2014) 0.80
Structure of S. aureus HPPK and the discovery of a new substrate site inhibitor. PLoS One (2012) 0.79
2,4-Diamino-5-(2'-arylpropargyl)pyrimidine derivatives as new nonclassical antifolates for human dihydrofolate reductase inhibition. J Mol Graph Model (2010) 0.79
Crystallization and preliminary X-ray analysis of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Staphylococcus aureus. Acta Crystallogr Sect F Struct Biol Cryst Commun (2010) 0.79
Propargyl-Linked Antifolates Are Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis. PLoS One (2016) 0.77
Charged Propargyl-Linked Antifolates Reveal Mechanisms of Antifolate Resistance and Inhibit Trimethoprim-Resistant MRSA Strains Possessing Clinically Relevant Mutations. J Med Chem (2016) 0.77
OSPREY Predicts Resistance Mutations Using Positive and Negative Computational Protein Design. Methods Mol Biol (2017) 0.75
MRSA Isolates from United States Hospitals Carry dfrG and dfrK Resistance Genes and Succumb to Propargyl-Linked Antifolates. Cell Chem Biol (2016) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr (1997) 137.43
Solving structures of protein complexes by molecular replacement with Phaser. Acta Crystallogr D Biol Crystallogr (2006) 16.41
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control (2004) 14.85
Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives. Clin Microbiol Infect (2006) 3.65
A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistance. J Mol Biol (1997) 2.16
MRSA--the tip of the iceberg. Clin Microbiol Infect (2006) 1.81
Highly efficient ligands for dihydrofolate reductase from Cryptosporidium hominis and Toxoplasma gondii inspired by structural analysis. J Med Chem (2007) 1.78
Characterization of the gene for the chromosomal dihydrofolate reductase (DHFR) of Staphylococcus epidermidis ATCC 14990: the origin of the trimethoprim-resistant S1 DHFR from Staphylococcus aureus? J Bacteriol (1995) 1.55
Structure-based approach to the development of potent and selective inhibitors of dihydrofolate reductase from cryptosporidium. J Med Chem (2008) 1.51
Structure-guided development of efficacious antifungal agents targeting Candida glabrata dihydrofolate reductase. Chem Biol (2008) 1.38
Methicillin-resistant Staphylococcus aureus: a new community-acquired pathogen? Curr Opin Infect Dis (2006) 1.32
Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections. Pharmacotherapy (2007) 1.28
Synthetic and crystallographic studies of a new inhibitor series targeting Bacillus anthracis dihydrofolate reductase. J Med Chem (2008) 1.26
Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria. Bioorg Med Chem Lett (2003) 1.19
Probing the active site of Candida glabrata dihydrofolate reductase with high resolution crystal structures and the synthesis of new inhibitors. Chem Biol Drug Des (2009) 1.14
Binding of coenzyme analogues to Lactobacillus casei dihydrofolate reductase: binary and ternary complexes. Biochemistry (1980) 1.01
Basis of selectivity of antibacterial diaminopyrimidines. J Chemother (1993) 1.00
Solution structure of human dihydrofolate reductase in its complex with trimethoprim and NADPH. J Biomol NMR (2005) 0.99
Furans, thiophenes and related heterocycles in drug discovery. Curr Opin Drug Discov Devel (2005) 1.82
Highly efficient ligands for dihydrofolate reductase from Cryptosporidium hominis and Toxoplasma gondii inspired by structural analysis. J Med Chem (2007) 1.78
Computational structure-based redesign of enzyme activity. Proc Natl Acad Sci U S A (2009) 1.77
A novel ensemble-based scoring and search algorithm for protein redesign and its application to modify the substrate specificity of the gramicidin synthetase a phenylalanine adenylation enzyme. J Comput Biol (2005) 1.66
Structure-based approach to the development of potent and selective inhibitors of dihydrofolate reductase from cryptosporidium. J Med Chem (2008) 1.51
Towards the understanding of resistance mechanisms in clinically isolated trimethoprim-resistant, methicillin-resistant Staphylococcus aureus dihydrofolate reductase. J Struct Biol (2009) 1.47
Selective inhibitor of proteasome's caspase-like sites sensitizes cells to specific inhibition of chymotrypsin-like sites. Chem Biol (2009) 1.47
The cycloaddition strategy for the synthesis of natural products containing carbocyclic seven-membered rings. Chemistry (2006) 1.46
The application of cathodic reductions and anodic oxidations in the synthesis of complex molecules. Chem Soc Rev (2006) 1.45
Predicting resistance mutations using protein design algorithms. Proc Natl Acad Sci U S A (2010) 1.41
Structure-guided development of efficacious antifungal agents targeting Candida glabrata dihydrofolate reductase. Chem Biol (2008) 1.38
Synthetic and crystallographic studies of a new inhibitor series targeting Bacillus anthracis dihydrofolate reductase. J Med Chem (2008) 1.26
Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action. Bioorg Med Chem Lett (2005) 1.21
OSPREY: protein design with ensembles, flexibility, and provable algorithms. Methods Enzymol (2013) 1.20
Toward new therapeutics for skin and soft tissue infections: propargyl-linked antifolates are potent inhibitors of MRSA and Streptococcus pyogenes. PLoS One (2012) 1.16
Phylogenetic classification of protozoa based on the structure of the linker domain in the bifunctional enzyme, dihydrofolate reductase-thymidylate synthase. J Biol Chem (2003) 1.16
Probing the active site of Candida glabrata dihydrofolate reductase with high resolution crystal structures and the synthesis of new inhibitors. Chem Biol Drug Des (2009) 1.14
Redesigning the PheA domain of gramicidin synthetase leads to a new understanding of the enzyme's mechanism and selectivity. Biochemistry (2006) 1.12
Design, synthesis, and biological evaluation of biotin conjugates of 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid for the isolation of the protein targets. J Med Chem (2004) 1.09
In pursuit of virtual lead optimization: the role of the receptor structure and ensembles in accurate docking. Proteins (2008) 1.01
Prospective screening of novel antibacterial inhibitors of dihydrofolate reductase for mutational resistance. Antimicrob Agents Chemother (2012) 0.99
In pursuit of virtual lead optimization: pruning ensembles of receptor structures for increased efficiency and accuracy during docking. Proteins (2009) 0.98
Structure-activity relationships of Bacillus cereus and Bacillus anthracis dihydrofolate reductase: toward the identification of new potent drug leads. Antimicrob Agents Chemother (2006) 0.97
In vitro biological activity and structural analysis of 2,4-diamino-5-(2'-arylpropargyl)pyrimidine inhibitors of Candida albicans. Bioorg Med Chem (2009) 0.96
Antifolate agents: a patent review (2006 - 2010). Expert Opin Ther Pat (2011) 0.95
Altered specificity of Hint-W123Q supports a role for Hint inhibition by ASW in avian sex determination. Physiol Genomics (2004) 0.95
Z-Phe-Ala-diazomethylketone (PADK) disrupts and remodels early oligomer states of the Alzheimer disease Aβ42 protein. J Biol Chem (2012) 0.94
Toward isozyme-selective inhibitors of histone deacetylase as therapeutic agents for the treatment of cancer. Pharm Pat Anal (2012) 0.94
Towards in silico lead optimization: scores from ensembles of protein/ligand conformations reliably correlate with biological activity. Proteins (2007) 0.94
Inhibitors of phosphoinositide-3-kinase: a structure-based approach to understanding potency and selectivity. Org Biomol Chem (2009) 0.92
Acetylenic linkers in lead compounds: a study of the stability of the propargyl-linked antifolates. Drug Metab Dispos (2012) 0.91
Crystal structures of Candida albicans dihydrofolate reductase bound to propargyl-linked antifolates reveal the flexibility of active site loop residues critical for ligand potency and selectivity. Chem Biol Drug Des (2011) 0.91
Targeted mutations of Bacillus anthracis dihydrofolate reductase condense complex structure−activity relationships. J Med Chem (2010) 0.90
Scoring ensembles of docked protein:ligand interactions for virtual lead optimization. J Chem Inf Model (2009) 0.87
Bicyclo[3.2.1]octane synthons from cyclopropenes: functionalization of cycloadducts by nucleophilic additions. J Org Chem (2004) 0.86
Development of intestinal organoids as tissue surrogates: cell composition and the epigenetic control of differentiation. Mol Carcinog (2013) 0.86
Structural analysis of the active sites of dihydrofolate reductase from two species of Candida uncovers ligand-induced conformational changes shared among species. Bioorg Med Chem Lett (2013) 0.86
Elucidating features that drive the design of selective antifolates using crystal structures of human dihydrofolate reductase. Biochemistry (2013) 0.85
Alpha-S-GalCer: synthesis and evaluation for iNKT cell stimulation. Bioorg Med Chem Lett (2008) 0.85
The furan route to tropolones: probing the antiproliferative effects of β-thujaplicin analogs. Org Biomol Chem (2012) 0.84
Towards new antifolates targeting eukaryotic opportunistic infections. Eukaryot Cell (2009) 0.84
A subgroup algorithm to identify cross-rotation peaks consistent with non-crystallographic symmetry. Acta Crystallogr D Biol Crystallogr (2004) 0.83
Analysis of complexes of inhibitors with Cryptosporidium hominis DHFR leads to a new trimethoprim derivative. Bioorg Med Chem Lett (2006) 0.83
The gem-dialkyl effect in electron transfer reactions: rapid synthesis of seven-membered rings through an electrochemical annulation. J Am Chem Soc (2005) 0.83
Cyclopropene cycloadditions with annulated furans: total synthesis of (+)- and (-)-frondosin B and (+)-frondosin A. J Am Chem Soc (2014) 0.82
Electrooxidative coupling of furans and silyl enol ethers: application to the synthesis of annulated furans. J Org Chem (2004) 0.82
Enhancing curcumin anticancer efficacy through di-block copolymer micelle encapsulation. J Biomed Nanotechnol (2014) 0.81
The solution structure of Bacillus anthracis dihydrofolate reductase yields insight into the analysis of structure-activity relationships for novel inhibitors. Biochemistry (2009) 0.81
2-cyano-3,12-dioxooleana-1,9(11)-diene-28-oic acid disrupts microtubule polymerization: a possible mechanism contributing to apoptosis. Mol Pharmacol (2006) 0.81
Propargyl-linked antifolates are dual inhibitors of Candida albicans and Candida glabrata. J Med Chem (2014) 0.81
Selective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-L-lactide) micelles leading to improved anti-tumor effects and low systematic toxicity. Int J Pharm (2013) 0.80
Two-step electrochemical annulation for the assembly of polycyclic systems. Org Lett (2002) 0.80
The crystal structure of dihydrofolate reductase-thymidylate synthase from Cryptosporidium hominis reveals a novel architecture for the bifunctional enzyme. J Eukaryot Microbiol (2003) 0.79
Synthesis of functionalized pyrans by domino metathesis reaction of oxabicyclo derivatives: dramatic effect of remote substituents on reactivity and selectivity. Angew Chem Int Ed Engl (2002) 0.79
2,4-Diamino-5-(2'-arylpropargyl)pyrimidine derivatives as new nonclassical antifolates for human dihydrofolate reductase inhibition. J Mol Graph Model (2010) 0.79
The structure of Cryptococcus neoformans thymidylate synthase suggests strategies for using target dynamics for species-specific inhibition. Acta Crystallogr D Biol Crystallogr (2005) 0.79
Toxoplasma gondii: generation of novel truncation mutations in the linker domain of dihydrofolate reductase-thymidylate synthase. Exp Parasitol (2004) 0.79
Natural products in parallel synthesis: triazole libraries of nonactic acid. Bioorg Med Chem Lett (2008) 0.78
Synthesis, in vitro and in vivo evaluation of new norcantharidin-conjugated hydroxypropyltrimethyl ammonium chloride chitosan derivatives as polymer therapeutics. Int J Pharm (2013) 0.78
Bridged synthons from tetrabromocyclopropene: studies on the rearrangement of the primary Diels-Alder adduct with 2,5-dimethylfuran. J Org Chem (2004) 0.78
Resolution of methyl nonactate by Rhodococcus erythropolis under aerobic and anaerobic conditions. Org Lett (2006) 0.78
Photocurable hard and porous biomaterials from ROMP precursors cross-linked with diyl radicals. Bioorg Med Chem Lett (2005) 0.78
Identification of novel compounds that enhance colon cancer cell sensitivity to inflammatory apoptotic ligands. Cancer Biol Ther (2013) 0.78
Electrochemical annulation of five-membered rings through dearomatization of furans and thiophenes. Chem Commun (Camb) (2005) 0.77
Dihydrofolate reductase inhibitors: developments in antiparasitic chemotherapy. Expert Opin Ther Pat (2008) 0.76
Silver-promoted reactions of bicyclo[3.2.1]octadiene derivatives. Org Lett (2002) 0.76
Possible paths and potential barriers to successfully modeling drug resistance. Future Med Chem (2013) 0.76
New chiral building blocks from tetrabromocyclopropene and furan. J Org Chem (2004) 0.76
The tandem ring opening/ring closing metathesis route to oxaspirocycles: an approach to phelligridin G. Molecules (2013) 0.76
Highly substituted oxabicyclic derivatives from furan: synthesis of (±)-platensimycin. Org Lett (2011) 0.75
Oxabicyclo[3.2.1]octane derivatives as highly reactive dienophiles: synthesis of bicyclo[5.n.0] systems. Org Lett (2005) 0.75
Natural product derivatives with bactericidal activity against Gram-positive pathogens including methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis. Bioorg Med Chem Lett (2010) 0.75